MCM
RXST icon

MAI Capital Management’s RxSight RXST Stock Holding History

MAI Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75K Buy
608
+602
+10,033% +$5K ﹤0.01% 3654
2025
Q4 		$63 Buy
+6
New +$60 ﹤0.01% 4214

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

MAI Capital Management's RXST Position: Q1 2026 in Review

MAI Capital Management increased its RxSight (RXST) stake by 10,033% in Q1 2026, buying an estimated $5K and bringing the position to 608 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

MAI Capital Management first reported a position in RXST in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • MAI Capital Management held 608 shares of RxSight worth $3.75K as of Q1 2026.
  • MAI Capital Management bought 602 RxSight shares in Q1 2026, an estimated $5K.
  • RxSight made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3654 holding.
  • MAI Capital Management first reported a position in RxSight in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.